Roles
- Professor of Otolaryngology, Neurological Surgery
-
Biography
Dr. Michael Hoffer is a Professor of Otolaryngology and Neurological Surgery at the University of Miami. Dr. Hoffer assumed these roles after an over twenty year military career in which he studied mild Traumatic Brain Injury (mTBI) on active duty service members. Dr. Hoffer is a clinician-scientist who performs both basic and clinical research along with his Otology/Neurotology clinical practice. Dr. Hoffer’s lab focuses on traumatic damage to the inner ear and brain. He is authored over seventy papers and several textbooks and has a particular expertise in hearing disorders, balance disorders, and dizziness as well as neurosensory consequences after mild traumatic brain injury (mTBI). Dr. Hoffer and his collaborators have done pioneering work on pharmaceutical countermeasures for mTBI as well as optimized diagnosis and management of neurosensory disorders seen after mTBI. Dr. Hoffer graduated from Stanford University and UCSD Medical School, was a resident at the University of Pennsylvania, and did a Neurotology Fellowship at the Ear Research Foundation. He has an active clinical practice in Otology/Neurotology and is very active in the University of Miami’s cochlear implant and hearing restoration services. -
Education & Training
Education
-
Teaching Interests
I am honored to have the opportunity to teach students at a variety of educational levels. I teach scientific principals underlying the pathophysiology of diseases of hearing and balance as well as basic science and research techniques. My formal teaching involves clinical otology and neurotology to medical students and residents and serving a the primary investigator and primary supervisor of doctoral and post-doctoral students. -
Research Interests
My research interests involve the diagnosis and treatment of traumatic head injury, dizziness, and hearing loss. Clinically I have focused work on treatment hearing loss and dizziness with a particular interest in adult and pediatric cochlear implants and single sided deafness. My clinical lab examines novel diagnostic and therapeutic techniques for mTBI and hearing loss and is involved in several clinical trials in these areas. My basic science lab is examining the pathophysiology and treatment of neurosensory disorders after brain injury. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Articles & News
Spanning the Gaps: Miller School Neurosensory Disorder Lab Works Across Medical Specialties
Leaders in ENT
Miller School’s Dr. Michael Hoffer Leads 2025 Triological Society Combined Sections Meeting
Disclaimer:
Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 4 clinical trials.
-
The objective of this clinical trial is to determine if Etanercept significantly reduces the severity of tinnitus associated with blast- or noise-exposure and yields persistent benefit, elucidating the mechanisms of action, and to identify factors that influence the therapeutic effects of Etanercept.
- Principal Investigator: Michael Hoffer
- Study Phase: Phase II
- Enrollment Status: Open
-
The Use of a Portable 3D Head Mounted Display (HMD) With Integrated Eye Capture Technology (IPAS Goggles) for the Diagnosis of Mild Traumatic Brain Injury (mTBI) in a Community Setting
- Principal Investigator: Michael Hoffer
- Study Phase: N/A
- Enrollment Status: Closed
-
The purpose of this research is to evaluate the safety, tolerability, usability and efficacy of a medication, N-acetylcysteine (NAC), for reducing post-concussive symptoms following a mild traumatic brain injury.
- Principal Investigator: Michael Hoffer
- Study Phase: TBD
- Enrollment Status: Open
-
Specific Aim 1: Examine the efficacy of ADVISOR to diagnose mTBI in individuals suffering a head injury that present to an emergency/urgent care facility compared to a control group of those presenting to the same facility with minor injuries not involving the headSpecific Aim 2: Examine optimal combination of assessments to rapidly assess and track progression of mTBI Specific Aim 3: Examine the efficacy of the ADVISOR system to predict mTBI recovery timelines Specific Aim 4: Examine the efficacy of the ADVISOR system to measure the progression of mTBI symptoms over time (vs. standard measures) Specific Aim 5: Evaluate the sensitivity and specificity of ADVISOR relative to similar devices. Specific Aim 6: Identify component tests that produce consistent and disparate classification pf subjects across devices.
- Principal Investigator: Michael Hoffer
- Study Phase: N/A
- Enrollment Status: Open